SAN RAMON, Calif., March 2, 2020—After seeing it on the horizon for so long, 2020 has been viewed by many as a culmination of efforts to advance facets of optometry. Yet for CooperVision, it marks the beginning of so much more to come.
“At SECO 2020, CooperVision will showcase our continued investment in innovation, education, sustainability, and partnerships to take on some of the greatest opportunities and challenges in eye health—helping eye care professionals to fit for the future,” said Simon Seshadri, CooperVision’s Vice President of Marketing, North America. “We are consistently strengthening and expanding the industry’s broadest contact lens portfolio, complemented by inventive programs and tools that enable ECPs to provide more patients with the highest standard of care—now and in the years to come.”
Developing Advanced Products for Optimal Outcomes
To help eye care professionals successfully transition astigmatic patients into their presbyopic years, CooperVision will share more information at its exhibit (#927) about the forthcoming Biofinity® toric multifocal contact lenses. The innovative lenses combine the proven optical design features of CooperVision’s Biofinity® toric—the most prescribed toric lens on the market1—and Biofinity® multifocal.
SECO attendees will also have the opportunity to learn firsthand about CooperVision’s Brilliant Futures™ Myopia Management Program, featuring MiSight® 1 day contact lenses. The comprehensive approach seeks to create a new standard of care for children with myopia. It provides inclusive practice, child and parent support to create the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. The groundbreaking MiSight® 1 day contact lenses recently became the first and only product approved by the U.S. Food and Drug Administration for slowing the progression of myopia in children (8-12 years of age at the initiation of treatment)2.
Experts will be available to discuss the Brilliant FuturesTM Myopia Management Program during the following times:
- Thursday, March 5 from 2:00 p.m. to 3:00 p.m.
- Friday, March 6 from 2:00 p.m. to 3:00 p.m.
- Saturday, March 7 from 1:00 p.m. to 2:00 p.m.
CooperVision will also offer lens fittings and on-eye exams for popular products in its portfolio—including clariti® 1 day, MyDay®, and Biofinity Energys® and Biofinity® toric—at the following times:
- Thursday, March 5 from 1:00 to 4:00 p.m.
- Friday, March 6 from 12:30 to 3:30 p.m.
- Saturday, March 7 from 11:30 a.m. to 2:30 p.m.
Education Leadership to Fight Myopia
As part of its commitment to advancing education about the increasing prevalence and severity of myopia in children—and options for myopia management, including MiSight® 1 day lenses—CooperVision will present several events:
Kids, Contacts and Myopia // OD Symposium Luncheon
Michele Andrews, OD, Senior Director, Professional & Academic Affairs, CooperVision
Friday, March 6, 12:00 to 1:00 p.m.
Location: Amphitheater A3
Kids, Contacts and Myopia // Opticians, Technicians, Administrators Lunch Symposium
Steven Rosinski, OD, Senior Manager, Professional & Academic Affairs, CooperVision
Friday, March 6, 12:00 to 1:00 p.m.
Location: Room 411/412
Kids and Contact Lenses // Student Symposium
Steven Rosinski, OD, Senior Manager, Professional & Academic Affairs, CooperVision
Saturday, March 7, 12:00 to 1:15 p.m.
Location: Room 411/412
Philanthropic Support for Optometry Initiatives
As a top-level Patriot Sponsor, CooperVision assists the Armed Forces Optometric Society (AFOS) in its mission to improve eye care for military personnel, veterans, and their families. At SECO, CooperVision will sponsor and participate in the organization’s biannual meeting on Wednesday, March 4.
Continued Commitment to Sustainability
CooperVision’s booth (#927) was designed with sustainability in mind, and visitors will have the opportunity to learn more about how the company is making strides in saving water, conserving energy, reducing, reusing and recycling resources, and empowering its people.
“Conferences like SECO provide us with an invaluable opportunity to meet face to face with eye care professionals—not only to update them on the latest innovations from CooperVision, but to hear about their experiences, needs, and what we can do to help,” said Seshadri. “We look forward to deepening these partnerships Atlanta.”
# # #
1 CVI data on file, 2019. US industry reports and internal estimates.
2 MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk
McDougall Communications for CooperVision, Inc.
heather@mcdougallpr.com or +1-585-434-2148